(CIDRAP News) – Dutch flu researcher Ron Fouchier, PhD, said he intends to submit a revised manuscript of his controversial mutated-H5N1 study to Science without applying for an export permit, according to a Nature News story today.
(CIDRAP News) – New details about H5N1 transmission studies emerged today during a Royal Society conference on the topic in London, but with Dutch export restrictions blocking what one research group could share.
(CIDRAP News) – A federal advisory board's reversal on publishing two controversial H5N1 studies is poised to shift discussions on the topic that continue in London this week, as more participants in the debate weigh in following the Mar 30 announcement.
(CIDRAP News) – A federal advisory board today reversed its stance on publishing two controversial H5N1 transmission papers today, recommending that both studies be published in full.
The National Science Advisory Board for Biosecurity (NSABB) met yesterday and today to discuss revised versions of the studies by two groups, one from the University of Wisconsin, Madison, and one from Erasmus University in the Netherlands.
(CIDRAP News) – Federal health officials today unveiled a new policy for overseeing life sciences dual-use research, such as two recent H5N1 transmission studies that have sparked bioterror concerns as well as cries of censorship.
(CIDRAP News) – As researchers from both sides of the debate over two controversial H5N1 studies weighed in yesterday on full publication versus a more cautionary approach, two US journals said they are developing policies to address any future such instances.
(CIDRAP News) – The lead researcher of one of the controversial H5N1 avian influenza transmission studies in ferrets said today that he hopes scientists can resume work on the studies in about 2 weeks, after key groups have discussed the issues.
(CIDRAP News) – Using the highest level of safety precautions for research on H5N1 viruses that can spread in mammals may slow the advance of science, but it's worth it in view of the grave risks involved, say some commentators writing today in mBio, a journal of the American Society for Microbiology (ASM).